Shu Zun-Hua, Wang Guo-Qiang, Li Ming-Quan, Wang Xiu-Ge
Zhongguo Zhen Jiu. 2014 Dec;34(12):1161-4.
To compare the efficacy on vertebrobasilar insufficiency (VBI) between auricular acupuncture therapy and oral administration of medicine.
Sixty patients of VBI were randomized into an auricular acupuncture therapy group and a medicine group, 30 cases in each one. In the auricular acupuncture group, acupuncture was applied bilaterally to gan (CO12) and jiejie (HX8) on the ears and needles were retained for 15 min. After needle withdrawal, the vaccariae semen were fixed with plaster at naogan (AT3, 4i), zhen (AT3), jing (AH12), shen (CO10) and pi (CO13) on the ears. In the medicine group, flunarizine hydrochloride capsules (Sibelium), 5mg were prescribed for oral administration, once every night. The treatment lasted continuously for 2 weeks (14 days) in the two groups. In 2 weeks, the clinical efficacy was assessed and the transcranial doppler (TCD) examination was performed.
After treatment, the symptom scores were all apparently reduced in the patients of the two groups (P < 0.01, P < 0.05). Compared with the medicine group, the reduced score was much more obvious in the auricular acupuncture group (P < 0.05), indicating the significant difference. After treatment, with TCD examination, the blood velocity was increased to different degrees in the patients of low velocity type in the auricular acupuncture group and the medicine group; that was reduced to different degrees in the patients of high velocity type in the auricular acupuncture group and the medicine group. All of them were different significantly as compared with those before treatment (all P < 0.05). But the difference was not significant between the two groups (both P > 0.05). In comparison of clinical efficacy between the two groups, the effective rate was 93.3% (28/30) in the acupuncture group and better than 76.7% (23/30) in the medicine group, indicating the significant difference in comparison (P < 0.05).
The auricular acupuncture therapy achieves the definite efficacy on VBI and the efficacy is better than flunarizine hydrochloride capsules.
比较耳针疗法与口服药物治疗椎基底动脉供血不足（VBI）的疗效。
将60例VBI患者随机分为耳针治疗组和药物组，每组30例。耳针组双侧针刺耳部的肝（CO12）、结节（HX8），留针15分钟。起针后，将王不留行籽用胶布固定于耳部的脑感（AT3，4i）、枕（AT3）、颈（AH12）、神门（CO10）和脾（CO13）。药物组口服盐酸氟桂利嗪胶囊（西比灵），5毫克，每晚1次。两组均连续治疗2周（14天）。2周后，评估临床疗效并进行经颅多普勒（TCD）检查。
治疗后，两组患者症状评分均明显降低（P<0.01，P<0.05）。与药物组相比，耳针组评分降低更明显（P<0.05），差异有统计学意义。治疗后，经TCD检查，耳针组和药物组低速型患者血流速度均有不同程度升高；耳针组和药物组高速型患者血流速度均有不同程度降低。与治疗前相比，差异均有统计学意义（均P<0.05）。但两组间差异无统计学意义（均P>0.05）。两组临床疗效比较，针刺组有效率为93.3%（28/30），优于药物组的76.7%（23/30），差异有统计学意义（P<0.05）。
耳针疗法治疗VBI疗效确切，且疗效优于盐酸氟桂利嗪胶囊。
